Last Updated: November 16, 2026

Details for Patent: 8,288,539

« Back to Dashboard


Summary for Patent: 8,288,539
Title:Dipeptidyl peptidase inhibitors
Abstract:Compounds, pharmaceuticals, kits and methods are provided for use with DPP-IV and other S9 proteases that comprise a compound comprising: wherein M is N or CR4; Q1 and Q2 are each independently selected from the group consisting of CO, SO, SO2, and C═NR9; and each L, X, R1, R2, and R3 are as defined herein.
Inventor(s):Jun Feng, Stephen L. Gwaltney, Jeffrey A. Stafford, Zhiyuan Zhang, Bruce J. Elder, Paul K. Isbester, Grant J. Palmer, Jonathon S. Salsbury, Luckner G. Ulysse
Assignee: Takeda Pharmaceutical Co Ltd
Application Number:US11/929,482
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,288,539
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 8,288,539

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,288,539

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1586571 ⤷  Start Trial C300640 Netherlands ⤷  Start Trial
European Patent Office 1586571 ⤷  Start Trial CA 2014 00011 Denmark ⤷  Start Trial
European Patent Office 1586571 ⤷  Start Trial PA2014011 Lithuania ⤷  Start Trial
European Patent Office 1586571 ⤷  Start Trial 14C0013 France ⤷  Start Trial
European Patent Office 1586571 ⤷  Start Trial 172 5006-2014 Slovakia ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.